Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial

被引：3

作者：

Alexander, Marliese ^{[1
,4
,14
]}

Collins, Ian ^{[6
,7
]}

Abraham, Patrick ^{[5
]}

Underhill, Craig ^{[12
,13
]}

Harris, Sam ^{[8
]}

Torres, Javier ^{[9
,10
]}

Sharma, Sharad ^{[11
]}

Solomon, Benjamin ^{[2
,4
]}

Tran-Duy, An ^{[5
]}

Burbury, Kate ^{[3
,4
]}

机构：

[1] Peter MacCallum Canc Ctr, Dept Pharm Dept, Melbourne, Australia

[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Australia

[3] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Australia

[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia

[5] Univ Melbourne, Ctr Hlth Policy, Melbourne Sch Populat & Global Hlth, Melbourne, Australia

[6] Victorian Comprehens Canc Ctr, Melbourne, Australia

[7] Deakin Univ, Melbourne, Australia

[8] Bendigo Hlth, Bendigo Canc Ctr, Bendigo, Australia

[9] Goulburn Valley Hlth, Peter Copulos Canc & Wellness Ctr, Shepparton, Australia

[10] Univ Melbourne, Shepparton Clin Sch, Shepparton, Australia

[11] Grampians Hlth, Ballarat Reg Integrated Canc Ctr, Ballarat, Vic, Australia

[12] Albury Wodonga Reg Canc Ctr, Border Med Oncol & Haematol Res Unit, Albury Wodonga, Australia

[13] Univ New South Wales, Rural Med Sch, Sydney, NSW, Australia

[14] Peter MacCallum Canc Ctr, Locked Bag 1ABeckett St, Melbourne, Vic 8006, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2023年 / 53卷 / 12期

基金：

英国医学研究理事会;

关键词：

cost analysis; teletrial; patient cost; cancer; clinical trial;

D O I：

10.1111/imj.16292

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018-2021; 6-month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity.

引用

页码：2346 / 2349

页数：4

共 50 条

[1] Understanding the financial cost of cancer clinical trial participation
Williams, Courtney P.
Deng, Luqin
Caston, Nicole E.
Gallagher, Kathleen
Angove, Rebekah
Pisu, Maria
Azuero, Andres
Arend, Rebecca
Rocque, Gabrielle B.
CANCER MEDICINE, 2024, 13 (08):
[2] The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial
Eric M. Thompson
Sridharan Gururangan
Gerald Grant
Duane Mitchell
John H. Sampson
Journal of Neuro-Oncology, 2017, 132 : 83 - 87
[3] The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial
Thompson, Eric M.
Gururangan, Sridharan
Grant, Gerald
Mitchell, Duane
Sampson, John H.
JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (01) : 83 - 87
[4] Implementing clinical trial results: a budget impact analysis
van 't Hooft, Janneke
Opmeer, Brent
Teune, Margreet
Versluis, Luuk
Mol, Ben
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S235 - S236
[5] Within-Trial Cost Analysis of Flares from a Phase 3 Clinical Trial Evaluating Subcutaneous Belimumab for the Treatment of Systemic Lupus Erythematosus
Lokhandwala, Tasneem
Yue, Binglin
Coutinho, Anna
Bell, Christopher
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[6] A randomized controlled trial to evaluate the impact of an educational DVD an cancer patients considering participation in a phase I clinical trial.
Strevel, E. L.
Newman, C.
Pond, G. R.
Maclean, M.
Siu, L. L.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 303S - 303S
[7] Implementing a phase I trial at a clinical research center: Defining oncology nursing roles.
Castro, K
Babb, R
ONCOLOGY NURSING FORUM, 2006, 33 (02) : 411 - 411
[8] Financial toxicity in early-phase cancer clinical trial participants
Durbin, Sienna M.
Lundquist, Debra
Pelletier, Andrea
Petrillo, Laura A.
Bame, Viola
Turbini, Victoria
Heldreth, Hope
Lynch, Kaitlyn
Boulanger, Mary
Lam, Anh
Mcintyre, Casandra
Ferrell, Betty R.
Jimenez, Rachel
Juric, Dejan
Nipp, Ryan D.
CANCER, 2025, 131 (01)
[9] IMPROVING CLINICAL TRIAL ACCESS TO RURAL, REGIONAL AND RARE CANCER PATIENTS-A TELEHEALTH APPROACH
Sabesan, Sabe
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 38 - 39
[10] Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology
Cambridge, Craig L.
Gatof, Emily Stern
Weiss, Glen J.
Davis, Roger B.
JOURNAL OF PATIENT-CENTERED RESEARCH AND REVIEWS, 2020, 7 (03) : 249 - 254

← 1 2 3 4 5 →